-
EP4073059
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP4073059
| EP4073059 - CGRP ANTIGONISTS USEFUL AS TRACER COMPOUNDS FOR POSITRON EMISSION TOMOGRAPHY [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 03.11.2023 Database last updated on 02.11.2024 | |
| Former | Request for examination was made Status updated on 16.09.2022 | ||
| Former | The international publication has been made Status updated on 18.06.2021 | ||
| Former | unknown Status updated on 15.01.2021 | Most recent event Tooltip | 03.11.2023 | Application deemed to be withdrawn | published on 06.12.2023 [2023/49] | Applicant(s) | For all designated states Eli Lilly and Company Lilly Corporate Center Indianapolis, IN 46285 / US | [2022/42] | Inventor(s) | 01 /
CHAPPELL, Mark Donald c/o ELI LILLY AND COMPANY P.O. Box 6288 Indianapolis, Indiana 46206-6288 / US | 02 /
SIEGEL, Miles Goodman c/o ELI LILLY AND COMPANY P.O. Box 6288 Indianapolis, Indiana 46206-6288 / US | [2022/42] | Representative(s) | Ingham, Stephen Howard Eli Lilly and Company Limited 8 Arlington Square West Downshire Way Bracknell, Berkshire RG12 1PU / GB | [2022/42] | Application number, filing date | 20830433.7 | 04.12.2020 | [2022/42] | WO2020US63401 | Priority number, date | US201962947043P | 12.12.2019 Original published format: US 201962947043 P | [2022/42] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2021118887 | Date: | 17.06.2021 | Language: | EN | [2021/24] | Type: | A1 Application with search report | No.: | EP4073059 | Date: | 19.10.2022 | Language: | EN | The application published by WIPO in one of the EPO official languages on 17.06.2021 takes the place of the publication of the European patent application. | [2022/42] | Search report(s) | International search report - published on: | EP | 17.06.2021 | Classification | IPC: | C07D401/12, C07D401/14, A61K31/435, C07B59/00 | [2022/42] | CPC: |
C07D401/14 (EP,US);
A61K51/0455 (US);
C07B59/002 (EP,US);
C07D401/12 (EP);
C07B2200/05 (US)
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2022/42] | Title | German: | CGRP-ANTIGONISTEN ALS TRACER-VERBINDUNGEN FÜR DIE POSITRONENEMISSIONSTOMOGRAFIE | [2022/42] | English: | CGRP ANTIGONISTS USEFUL AS TRACER COMPOUNDS FOR POSITRON EMISSION TOMOGRAPHY | [2022/42] | French: | ANTIGONISTES CGRP UTILES EN TANT QUE COMPOSÉS TRACEURS POUR LA TOMOGRAPHIE PAR ÉMISSION DE POSITRONS | [2022/42] | Entry into regional phase | 12.07.2022 | National basic fee paid | 12.07.2022 | Designation fee(s) paid | 12.07.2022 | Examination fee paid | Examination procedure | 06.07.2022 | Amendment by applicant (claims and/or description) | 12.07.2022 | Examination requested [2022/42] | 12.07.2022 | Date on which the examining division has become responsible | 01.02.2023 | Loss of particular rights, legal effect: Claims | 22.02.2023 | Despatch of communication of loss of particular rights: Claims {1} | 01.07.2023 | Application deemed to be withdrawn, date of legal effect [2023/49] | 27.07.2023 | Despatch of communication that the application is deemed to be withdrawn, reason: renewal fee not paid in time [2023/49] | Fees paid | Penalty fee | Additional fee for renewal fee | 31.12.2022 | 03 M06 Not yet paid |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [A]WO2017027345 (LILLY CO ELI [US]) [A] 1-23 * the whole document *; | [A]WO2018213059 (LILLY CO ELI [US]) [A] 1-23 * the whole document *; | [A] - SALVATORE C A ET AL, "Cgrp receptor antagonists: Toward a novel migraine therapy", CURRENT PHARMACEUTICAL BIOTECHNOLOGY, BENTHAM SCIENCE PUBLISHERS, NL, (20111001), vol. 12, no. 10, doi:10.2174/138920111798357401, ISSN 1389-2010, pages 1671 - 1680, XP009181323 [A] 1-17 * the whole document * DOI: http://dx.doi.org/10.2174/138920111798357401 | by applicant | US9637495 | US9708297 | - S.G.G. VERMEERSCH et al., The Journal of Headache and Pain, (20130000), vol. 14, page 224 | - I.M. BELL et al., Medicinal Chemistry Letters, (20130000), vol. 4, pages 863 - 868 | - GOULD, P.L., "Salt selection for basic drugs", International Journal of Pharmaceutics, (19860000), vol. 33, doi:10.1016/0378-5173(86)90055-4, pages 201 - 217, XP025813036 DOI: http://dx.doi.org/10.1016/0378-5173(86)90055-4 | - BASTIN, R.J. et al., "Salt Selection and Optimization Procedures for Pharmaceutical New Chemical Entities", Organic Process Research and Development, (20000000), vol. 4, pages 427 - 435 | - BERGE, S.M. et al., "Pharmaceutical Salts", Journal of Pharmaceutical Sciences, (19770000), vol. 66, doi:10.1002/jps.2600660104, pages 1 - 19, XP002675560 DOI: http://dx.doi.org/10.1002/jps.2600660104 | - B. LIUB.-F. SHI, Tet. Lett, (20150101), vol. 56, no. 1, pages 15 - 22 | - V. P. SHEVCHENKOI. YU. NAGAEVN. F. MYASOEDOVA. B. SUSANK.-H. SWITEKH. BRAUNGER, J Label Compd Radiopharm, (20060000), vol. 49, pages 421 - 427 | - DESAI et al., Mol Pharm, (20130000), vol. 10, pages 1249 - 1261 |